52687Posted: 17/07/2026London , United Kingdom Permanent Account Executive β AI Drug Discovery SoftwareUK | Remote/HybridWe're partnering with a growing scientific software company developing AI-powered molecular design technology used by drug discovery teams to make faster, more informed R&D decisions. This is a mid-market Account Executive position focused on developing new business and growing existing customer relationships across biotech, pharma, and drug discovery organisations. We're looking for someone with:3β5 years' commercial experience selling into the life sciences sectorA track record of winning and growing customer accountsExperience managing sales processes from initial engagement through to closeThe ability to build credibility with both scientific and business stakeholdersStrong communication, presentation, and relationship-building skillsA proactive, self-driven approach in a growing commercial environmentUseful background (not essential):Scientific software, SaaS, drug discovery technology, or AI-enabled platformsExposure to biotech, pharma, CROs, or research organisationsThe opportunity: Join a growing company operating at the intersection of AI and drug discoveryWork with innovative biotech and pharmaceutical customersTake ownership of a defined territory and contribute directly to commercial growthThis role is likely to suit an Account Executive / Account Manager looking to build a career within scientific software, AI, or drug discovery technology.
Account Manager/Executives (Permanent) employer: Barrington James
Barrington James is an exceptional employer that fosters a collaborative and innovative work culture, making it an ideal place for professionals in Epidemiology and Real-World Evidence. With a strong emphasis on employee growth, we offer tailored development opportunities and the chance to lead impactful projects across diverse therapeutic areas in the dynamic UK/Europe market. Join us to be part of a team that values flexibility, creativity, and meaningful contributions to healthcare advancements.